跳至主要内容
临床试验/ACTRN12608000476336
ACTRN12608000476336招募中4 期

International Study to Predict Optimized Treatment response to the three most commonly used antidepressants (Escitalopram, Sertraline and Venlafaxine extended release XR,) in subjects diagnosed with major depressive disorder (MDD) as compared to matched healthy controls.

Brain Resource0 个研究点目标入组 2,688 人开始时间: 2008年9月24日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
2,688

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Educational / counselling / training
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Meet Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)criteria for primary Major Depressive Disorder with a Hamilton Rating Depression Scale (HAM-D) score >/= 16 and who are fluent in English or Dutch.

排除标准

  • Presence of suicidal ideations, biopoloar, psychosis or primary eating disorder.
  • Prior or resent use antidepressants including escitalopram, sertraline, venlafaxine XR.
  • History of brain injury/blow resulting in loss of consciousness.
  • evere impediment to vision, hearing and/or hand movement which may interfere with their ability to complete the protocol required test.

研究者

发起方
Brain Resource

相似试验